A significant advance in cancer study is occurring with the use of VHH fragments to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently lost in several types of malignancies, leading https://minibookmarking.com/story22079531/mini-antibodies-reactivate-tumor-suppressor-p53-the-promising-hope-for-tumor-treatment